journal article·2024-08Open access

Region‐Specific CD16+ Neutrophils Promote Colorectal Cancer Progression by Inhibiting Natural Killer Cells

Yan Zhang, Zien Wang, Yu Lu, David J. Sanchez, Jiaojiao Li, Linghao Wang, Xiaoxue Meng, Jianjun Chen, Tran Trung Kien, Ming Zhong, Wei‐Qiang Gao, Xianting Ding

Advanced Science· Volume 11· Issue 29

Abstract

Abstract The colon is the largest compartment of the immune system, with innate immune cells exposed to antigens in the environment. However, the mechanisms by which the innate immune system is instigated are poorly defined in colorectal cancer (CRC). Here, a population of CD16+ neutrophils that specifically accumulate in CRC tumor tissues by imaging mass cytometry (IMC), immune fluorescence, and flow cytometry, which demonstrated pro‐tumor activity by disturbing natural killer (NK) cells are identified. It is found that these CD16+ neutrophils possess abnormal cholesterol accumulation due to activation of the CD16/TAK1/NF‐κB axis, which upregulates scavenger receptors for cholesterol intake including CD36 and LRP1. Consequently, these region‐specific CD16+ neutrophils not only competitively inhibit cholesterol intake of NK cells, which interrupts NK lipid raft formation and blocks their antitumor signaling but also release neutrophil extracellular traps (NETs) to induce the death of NK cells. Furthermore, CD16‐knockout reverses the pro‐tumor activity of neutrophils and restored NK cell cytotoxicity. Collectively, the findings suggest that CRC region‐specific CD16+ neutrophils can be a diagnostic marker and potential therapeutic target for CRC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immune cells in cancer · Immune Cell Function and Interaction · Neutrophil, Myeloperoxidase and Oxidative Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Systems Medicine for Cancer Renji Hospital School of Biomedical Engineering Shanghai Jiao Tong University Shanghai 200030 China

Med‐X Research Institute & School of Biomedical Engineering Shanghai Jiao Tong University Shanghai 200030 China

Pharmaceutical Sciences Department College of Pharmacy Western University of Health Sciences 309 East 2nd Street HPC 225 Pomona CA 90025 USA

School of Biomedical Engineering Faculty of Engineering and IT University of Technology Sydney Sydney NSW 2007 Australia

Department of Gastrointestinal Surgery Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai 200127 China

Oncology department University Medical Shing Mark Hospital 1054 Highway 51, Long Binh Tan Ward, Bien Hoa City Dong Nai 76000 Vietnam

State Key Laboratory of Oncogenes and Related Genes Institute for Personalized Medicine School of Biomedical Engineering Shanghai Jiao Tong University Shanghai 200030 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Higher Education Discipline Innovation Project · Science and Technology Commission of Shanghai Municipality · Key Technologies Research and Development Program

References (70)

Show source-provided references
1. 10.3322/caac.2176310.3322/caac.21763 ↗
2. 10.1038/s41575-021-00569-410.1038/s41575-021-00569-4 ↗
3. 10.1038/s41571-020-0422-y10.1038/s41571-020-0422-y ↗
4. 10.1186/s40779-017-0122-910.1186/s40779-017-0122-9 ↗
5. 10.1038/nri373810.1038/nri3738 ↗
6. 10.3389/fimmu.2021.61282610.3389/fimmu.2021.612826 ↗
7. 10.1016/j.it.2010.05.00610.1016/j.it.2010.05.006 ↗
8. 10.1038/nrc.2016.5210.1038/nrc.2016.52 ↗
9. 10.1371/journal.ppat.100465110.1371/journal.ppat.1004651 ↗
10. 10.1016/j.trecan.2016.12.00610.1016/j.trecan.2016.12.006 ↗
11. 10.1182/blood-2018-11-84454810.1182/blood-2018-11-844548 ↗
12. 10.1084/jem.2022001110.1084/jem.20220011 ↗
13. 10.1038/s41568-020-0281-y10.1038/s41568-020-0281-y ↗
14. 10.1016/j.ccr.2009.06.01710.1016/j.ccr.2009.06.017 ↗
15. 10.1186/s13046-015-0256-010.1186/s13046-015-0256-0 ↗
16. 10.1136/jitc-2020-00230510.1136/jitc-2020-002305 ↗
17. 10.1158/1078-0432.CCR-19-262510.1158/1078-0432.CCR-19-2625 ↗
18. 10.1111/imm.1243710.1111/imm.12437 ↗
19. 10.1158/2326-6066.CIR-15-003610.1158/2326-6066.CIR-15-0036 ↗
20. 10.1016/j.it.2019.01.00610.1016/j.it.2019.01.006 ↗
21. 10.1016/j.ccell.2020.12.01210.1016/j.ccell.2020.12.012 ↗
22. 10.1084/jem.2018221810.1084/jem.20182218 ↗
23. 10.3390/ijms2214726010.3390/ijms22147260 ↗
24. 10.1186/s13045-021-01103-410.1186/s13045-021-01103-4 ↗
25. 10.1016/j.redox.2019.10129710.1016/j.redox.2019.101297 ↗
26. 10.1053/j.gastro.2019.05.00410.1053/j.gastro.2019.05.004 ↗
27. 10.1158/1078-0432.CCR-17-372610.1158/1078-0432.CCR-17-3726 ↗
28. 10.1016/j.jaci.2020.08.04210.1016/j.jaci.2020.08.042 ↗
29. 10.1038/s41598-017-03256-010.1038/s41598-017-03256-0 ↗
30. 10.1016/j.immuni.2013.02.01010.1016/j.immuni.2013.02.010 ↗
31. 10.1038/s41571-020-0426-710.1038/s41571-020-0426-7 ↗
32. 10.1182/blood-2016-12-75383010.1182/blood-2016-12-753830 ↗
33. 10.1136/jitc-2021-00286610.1136/jitc-2021-002866 ↗
34. 10.1053/j.gastro.2020.01.02810.1053/j.gastro.2020.01.028 ↗
35. 10.1017/S095442242000012810.1017/S0954422420000128 ↗
36. 10.1016/j.cmet.2021.02.01510.1016/j.cmet.2021.02.015 ↗
37. 10.1016/j.plipres.2022.10116410.1016/j.plipres.2022.101164 ↗
38. 10.1161/CIRCULATIONAHA.117.03263610.1161/CIRCULATIONAHA.117.032636 ↗
39. 10.1016/j.cell.2017.10.00310.1016/j.cell.2017.10.003 ↗
40. 10.1016/j.actbio.2021.06.00710.1016/j.actbio.2021.06.007 ↗
41. 10.1007/s10456-021-09787-510.1007/s10456-021-09787-5 ↗
42. 10.1182/blood-2014-04-56978010.1182/blood-2014-04-569780 ↗
43. 10.1038/s41423-019-0202-810.1038/s41423-019-0202-8 ↗
44. 10.1126/science.abc026910.1126/science.abc0269 ↗
45. 10.1146/annurev-biochem-062917-01185210.1146/annurev-biochem-062917-011852 ↗
46. 10.1038/nrm.2017.1610.1038/nrm.2017.16 ↗
47. 10.1084/jem.2020205910.1084/jem.20202059 ↗
48. 10.1016/j.cell.2019.04.04110.1016/j.cell.2019.04.041 ↗
49. 10.1146/annurev-immunol-032712-09595110.1146/annurev-immunol-032712-095951 ↗
50. 10.1038/s41586-019-1167-610.1038/s41586-019-1167-6 ↗
51. 10.1136/gutjnl-2021-32607010.1136/gutjnl-2021-326070 ↗
52. 10.1038/s41577-021-00534-x10.1038/s41577-021-00534-x ↗
53. 10.1186/s13045-019-0710-010.1186/s13045-019-0710-0 ↗
54. 10.1146/annurev-immunol-042617-05311910.1146/annurev-immunol-042617-053119 ↗
55. 10.1002/ijc.2560910.1002/ijc.25609 ↗
56. 10.1158/1078-0432.CCR-16-204710.1158/1078-0432.CCR-16-2047 ↗
57. 10.1016/j.immuni.2020.12.00310.1016/j.immuni.2020.12.003 ↗
58. 10.1016/j.ccell.2021.03.00410.1016/j.ccell.2021.03.004 ↗
59. 10.1038/s41564-019-0541-310.1038/s41564-019-0541-3 ↗
60. 10.1038/s41586-022-05400-x10.1038/s41586-022-05400-x ↗
61. 10.1016/j.humpath.2017.08.02810.1016/j.humpath.2017.08.028 ↗
62. 10.1016/j.ejca.2019.09.00810.1016/j.ejca.2019.09.008 ↗
63. 10.1016/j.immuni.2020.03.00110.1016/j.immuni.2020.03.001 ↗
64. 10.1016/j.semcancer.2022.01.00610.1016/j.semcancer.2022.01.006 ↗
65. 10.1038/s41423-019-0206-410.1038/s41423-019-0206-4 ↗
66. 10.1016/j.omto.2021.11.01610.1016/j.omto.2021.11.016 ↗
67. 10.1158/0008-5472.CAN-16-191610.1158/0008-5472.CAN-16-1916 ↗
68. 10.1002/eji.20083886310.1002/eji.200838863 ↗
69. 10.1038/nri.2017.10510.1038/nri.2017.105 ↗
70. 10.1038/ni.263910.1038/ni.2639 ↗